anti-Herpes Simplex Virus Type-2 (HSV-2) Glycoprotein D antibody product blog
Tags: Antibody; Monoclonal Antibody; Herpes Simplex Virus Type-2 (HSV-2) Glycoprotein D; anti-Herpes Simplex Virus Type-2 (HSV-2) Glycoprotein D antibody;
The Herpes Simplex Virus Type-2 (HSV-2) Glycoprotein D n/a (Catalog #MBS310429) is an Antibody produced from Mouse. Hybridization of Sp2/0 myeloma cells with spleen cells from Balb/c mice. and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Herpes Simplex Virus Type-2 (HSV-2) Glycoprotein D can be used in a range of immunoassay formats including, but not limited to, Western Blot. Researchers should empirically determine the suitability of the Herpes Simplex Virus Type-2 (HSV-2) Glycoprotein D n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Purified Herpes Simplex Virus from strain BH
Affinity Constant: Not determined. Buffer: PBS, pH 7.4
Preservative: 0.1% Sodium azide
Important Note: Centrifuge before opening to ensure complete recovery of vial contents.
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Herpes Simplex Virus Type-2 (HSV-2) Glycoprotein D are readily searchable from our website. Different antibodies against the same target such as Herpes Simplex Virus Type-2 (HSV-2) Glycoprotein D may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.